Mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene possess the strongest risk factor in the development of PAH, particularly heritable PAH (Machado et al., 2006). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.